Plexus Corp (PLXS) CEO executes 1,500-share Rule 10b5-1 stock sale
Plexus Corp's President and CEO, Todd P. Kelsey, sold 1,500 shares of common stock on May 20, 2026, in open-market transactions valued at approximately $252-$253 per share. These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted in November 2025, indicating that they were planned for portfolio diversification rather than being based on discretionary timing. After these transactions, the CEO retains a substantial direct shareholding in the company.
Plexus Corp. (NASDAQ:PLXS) Receives Average Recommendation of "Moderate Buy" from Analysts
Plexus Corp. (NASDAQ:PLXS) has garnered a "Moderate Buy" rating from analysts, with five buy and two hold recommendations, and an average 12-month price target of approximately $229.17. The company's recent quarterly results surpassed expectations, reporting $2.05 EPS against a $1.87 consensus and $1.16 billion in revenue, an 18.7% year-over-year increase. Despite recent insider selling, institutional investors retain a significant majority of shares in the company.
Plexus Corp stock (US7291321005): electronics manufacturer updates investors after latest quarterly
Plexus Corp, an electronics manufacturer, recently updated investors on its latest quarterly results, reporting approximately $996 million in net sales for Q1 2025 and a book-to-bill ratio above one. The company specializes in complex, high-reliability products for healthcare, industrial, aerospace, and communications markets. It focuses on end-to-end services, emphasizing engineering capabilities, regulatory expertise, and a regional manufacturing footprint to meet evolving market demands and supply chain needs.
Todd Kelsey reports three stock sales at Plexus (NASDAQ: PLXS)
Todd P. Kelsey, an insider at Plexus (NASDAQ: PLXS), reported three separate sales of Common Stock in early May 2026. The transactions involved 2,403 shares on May 4, 3,000 shares on May 5, and 1,000 shares on May 6, with corresponding numeric values listed for each sale. The filing also provides context regarding prior compensation-related vesting of Restricted Stock Units and Performance Stock Units in early 2025.
Riverside Research and Plexus Corp Form Partnership to Rapidly Develop Designs for Reusable Modular-Based Hardware and Software for the Intelligence and Defense Markets
Riverside Research and Plexus Corp. have announced a strategic partnership to accelerate the development of reusable modular-based hardware and software for the intelligence and defense sectors. Their initial collaboration resulted in the Aegis R52L Enhanced Retransmission Device, which moved from concept to manufacturing planning in under nine months, demonstrating a rapid prototyping approach for secure connected devices. This partnership aims to deliver more advanced capabilities and faster market entry for ultra-secure technologies.
Plexus Corp stock (US7291321005): GSA Capital stake filing puts PLXS back in focus
Plexus Corp (PLXS), an electronics manufacturing services company, is back in focus after a recent filing showed GSA Capital Partners LLP bought shares, adding a fresh ownership signal. The company's business model is tied to program wins, lifecycle demand, and execution quality across aerospace/defense, healthcare/life sciences, and industrial customers. This activity, combined with operational signals like partnerships and hiring, suggests continued institutional interest in PLXS as investors monitor earnings, guidance, and customer updates.
Riverside Research Announces Strategic Partnership with Plexus Corp.
Riverside Research has partnered with Plexus Corp. to accelerate the development of reusable, modular hardware and software for the intelligence and defense markets. Their first collaboration, the Aegis R52L Enhanced Retransmission Device, was developed in under nine months, addressing security concerns and reducing time-to-market for connected devices. This partnership aims to combine their expertise to deliver advanced, secure technologies more rapidly to market.
Plexus (PLXS) price target increased by 30.22% to 279.99
This article reports that the price target for Plexus (PLXS) has been increased by 30.22% to $279.99. No further details or context regarding this change are provided within the article content.
Plexus' Q2 earnings surpass estimates, revenues increase Y/Y
Plexus (PLXS) reported stronger-than-expected Q2 earnings, with diluted EPS of $1.52 exceeding the consensus estimate of $1.39. Revenue also saw a year-over-year increase, reaching $1.02 billion against an estimated $1.00 billion. The company anticipates Q3 diluted EPS to be between $1.28 and $1.43, with revenue projected to be between $970 million and $1.01 billion.
Plexus Corp. - Common Stock (NQ: PLXS)
This article provides recent news headlines and financial updates for Plexus Corp. (NASDAQ: PLXS), an electronic manufacturing services company. It includes reports on quarterly earnings, analyst forecasts, and discussions of stock performance, highlighting Plexus's Q1 FY2025 revenue meeting expectations and upcoming earnings release dates. The compilation offers insights into the company's financial health, market sentiment, and broader industry trends.
Plexus Corp stock (US7291321005): Insider sells 3,000 shares
Plexus Corp's APAC Regional President, Victor Tan, sold 3,000 shares of common stock on May 11, 2026, at an average price of $271.23 per share. Following this transaction, Tan directly holds 10,457 shares. Plexus Corp specializes in electronics manufacturing services for healthcare, industrial, and aerospace sectors.
Insider Sell: Tan Victor (Pang Hau) Sells 3,000 Shares of Plexus Corp (PLXS)
Tan Victor (Pang Hau), Regional President - APAC of Plexus Corp (PLXS), sold 3,000 shares of the company on May 11, 2026. This transaction increased his total shares sold over the past year to 9,000, with no purchases. Shares were trading at $271.23, and the stock is considered significantly overvalued with a price-to-GF-Value ratio of 1.87.
Number of shareholders of Plexus Corp. – DUS:PX4
This article provides details on the number of shareholders for Plexus Corp. (DUS:PX4). It appears to be a financial data page from TradingView, offering an overview of the company's financials for investors and highlighting the availability of this specific shareholder metric over various periods.
Plexus Corp (PLXS) APAC regional president sells 3,000 shares
Plexus Corp's Regional President for APAC, Victor (Pang Hau) Tan, reported the open-market sale of 3,000 shares of PLXS common stock on May 11, 2026. The shares were sold at a weighted average price of $271.2333 per share, bringing his direct holdings down to 10,457 shares. This transaction is considered to have a very high negative filing impact.
Plexus Insider Sold Shares Worth $813,700, According to a Recent SEC Filing
An insider at Plexus Corp. sold shares valued at $813,700, as reported in a recent SEC filing. This transaction follows another insider sale of $1,710,239 worth of shares just days prior. Plexus Corp. (PLXS) recently reported its Q2 2026 earnings, with adjusted earnings and revenue rising, and announced a CFO transition.
Proposed sale of 3,312 PLXS shares by Morgan Stanley (PLXS)
A Form 144 filing by Morgan Stanley indicates a proposed sale of 3,312 shares of Plexus Corp (PLXS) related to restricted stock vesting from May 12, 2025. The filing also reports a recent sale of 3,815 shares on May 6, 2026, for gross proceeds of $1,026,006.10, with a neutral impact and sentiment according to Rhea-AI.
Argos Wealth Advisors LLC Purchases Shares of 5,711 Plexus Corp. $PLXS
Argos Wealth Advisors LLC recently acquired 5,711 shares of Plexus Corp. (NASDAQ:PLXS) during the fourth quarter, valued at approximately $840,000, establishing a new position in the company. Despite significant insider selling over the past 90 days, with CEO Todd P. Kelsey and CFO Patrick John Jermain reducing their holdings, Plexus reported strong quarterly earnings, beating both EPS and revenue estimates. The company maintains a "Moderate Buy" analyst rating with an average price target of $229.17.
[Form 3] PLEXUS CORP Initial Statement of Beneficial Ownership
Plexus Corp's Senior Vice President and CFO, David Westen Abuhl, has filed an initial statement of beneficial ownership (Form 3) disclosing his equity awards. The filing details his holdings of 1,760 Performance Stock Units (PSUs) and 8,750 Restricted Stock Units (RSUs), granted between 2025 and 2026 under the company's 2024 Omnibus Incentive Plan. These awards are subject to vesting schedules and performance conditions related to total shareholder return and economic return goals.
Plexus (PLXS) EVP sells 5,568 shares in open-market trades
Plexus Corp's EVP Angelo Michael Ninivaggi Jr reported selling 5,568 shares of company common stock in open-market transactions on May 7–8, 2026, at weighted average prices ranging from $262.00 to $266.20 per share. Following these sales, he directly retains 16,266 shares. This transaction is considered a routine-sized sale by an executive and primarily serves as an ownership disclosure rather than a strong signal about the company's broader financial outlook.
PLXS (NASDAQ: PLXS) Form 144 lists 3,000 common shares for sale via Morgan Stanley
A Form 144 filing for Plexus Corp (NASDAQ: PLXS) indicates a proposed sale of 3,000 common shares through Morgan Stanley Smith Barney LLC Executive Financial Services on May 11, 2026. The filing also details several Performance Stock Units with various grant dates. Experts assess the filing as neutral, indicating a routine administrative resale notice with no immediate material impact on capitalization or dilution based on the provided excerpt.
Plexus' Q2 earnings surpass estimates, revenues increase Y/Y
Plexus (PLXS) reported stronger-than-expected Q2 earnings, with EPS of $1.29 beating estimates by $0.16 and revenue of $1.03 billion, which was up 4.6% year-over-year, exceeding expectations by $30 million. The company's Q3 revenue guidance is projected to be between $1.03 billion and $1.07 billion, with an EPS forecast of $1.18 to $1.33.
Is Stronger Earnings and CFO Transition Altering The Investment Case For Plexus (PLXS)?
Plexus (PLXS) recently reported strong second-quarter and six-month results with increased sales, net income, and EPS, alongside positive Q3 guidance. The company also announced the upcoming retirement of its CFO, Patrick Jermain, and the appointment of David Abuhl, which, combined with continued share repurchases, could influence its investment narrative. While the stronger earnings support Plexus's focus on high-value electronics manufacturing, investors should remain aware of potential demand instability in core markets like semicap and aerospace.
Is Stronger Earnings and CFO Transition Altering The Investment Case For Plexus (PLXS)?
Plexus Corp. (PLXS) reported stronger Q2 results with increased sales, net income, and EPS, and issued positive Q3 guidance. The company also announced the retirement of its long-serving CFO and confirmed ongoing share repurchases. These developments, along with continued focus on complex electronics manufacturing, are expected to influence Plexus' investment narrative despite concerns about market cyclicality and customer concentration.
Trading Systems Reacting to (PLXS) Volatility
This article from Stock Traders Daily discusses AI-generated trading strategies for Plexus Corp. (NASDAQ: PLXS), indicating a near-term neutral sentiment amidst mid and long-term strength. It outlines specific position trading, momentum breakout, and risk hedging strategies, along with multi-timeframe signal analysis, providing entry, target, and stop-loss levels.
UBS Group AG Sells 28,199 Shares of Plexus Corp. $PLXS
UBS Group AG reduced its stake in Plexus Corp. by 10.9% in the fourth quarter, selling 28,199 shares and retaining 231,508 shares valued at $34.0 million. Despite recent insider selling by executives like CEO Todd P. Kelsey and COO Oliver K. Mihm, institutional ownership remains high at 94.45%. Plexus exceeded quarterly earnings expectations with an EPS of $2.05 and revenue of $1.16 billion, and the stock is trading near its 52-week high.
Have Insiders Sold Plexus Shares Recently?
Plexus Corp. insiders have recently sold shares, with President Todd Kelsey selling US$1.7m and Non-Executive Chairman Dean Foate selling US$2.1m, both below the current share price. Despite these sales and no insider purchases in the last year, insider ownership remains at 1.6% (US$111m), which is considered a positive sign for shareholder alignment. However, the selling activity, particularly at values lower than the current price, does not instill confidence, although the company is profitable and growing.
[Form 4] PLEXUS CORP Insider Trading Activity
Plexus Corp.'s Exec. VP & CFO, Patrick John Jermain, reported a discretionary transaction involving 3,815 shares of common stock previously held in the company's 401(k) Savings Plan. This transaction, executed on May 6, 2026, at $268.9356 per share, resulted in his direct holdings increasing to 17,534 shares and 401(k) holdings becoming zero. The filing details the change in beneficial ownership as per SEC Form 4.
2,298-share sale reported for PLXS (PLXS)
A director of Plexus Corp (PLXS), Angelo M. Ninivaggi, reported the sale of 2,298 common shares on May 7, 2026, for an aggregate consideration of $604,340.22. The sale was disclosed in a Form 144 filing, which also listed Performance Stock Units granted in 2022 and 2025. This filing is part of routine transparency for insider transactions.
PLXS News & Events
Plexus (PLXS) reported strong Q2 2026 earnings, exceeding revenue and EPS guidance with significant year-over-year growth across all market sectors. The company achieved record manufacturing wins and robust profitability, with its President and CEO highlighting accelerating momentum. The article also lists various news headlines related to PLXS, including earlier earnings reports and stock performance milestones.
PLXS (NASDAQ: PLXS) Form 144 shows proposed common stock sale via Fidelity
A Form 144 filing for Plexus Corp (PLXS) indicates a proposed sale of common stock facilitated by Fidelity Investments, with a filing date of May 8, 2026. The filing details multiple prior stock awards to Michael V. Schrock between 2022 and 2025. The document provides key figures related to the proposed sale and clarifies the regulatory context of Form 144 and NASDAQ.
Have Insiders Sold Plexus Shares Recently?
Plexus Corp. insiders have recently sold shares, with the President selling US$1.7m worth and the Non-Executive Chairman selling US$2.1m, both at or slightly below the current share price. While these sales represent a small percentage of their total holdings and the company is profitable, the article notes a lack of insider buying over the last year, suggesting some caution despite strong insider ownership of 1.6%.
Rule 144 sale filing (NASDAQ: PLXS) lists 1,771 and 527 shares
A Rule 144 filing for Plexus Corp (PLXS) indicates a proposed sale of common stock, stemming from restricted stock vesting and performance stock units. The filing details 1,771 shares and 527 shares with grant/vesting dates of January 21, 2022, and February 16, 2022, respectively. Morgan Stanley Smith Barney LLC is listed as the broker/custodian for these transactions, with the filing date being May 7, 2026.
Plexus (NASDAQ: PLXS) Q2 2026 revenue up 18.7% to $1.16B
Plexus Corp. reported strong financial results for Q2 2026, with net sales increasing by 18.7% to $1.16 billion and net income rising to $49.8 million. Diluted EPS reached $1.82, driven by broad-based demand across all regions and market sectors. Despite robust revenue and margin expansion, the company experienced weakened cash generation and negative free cash flow due to increased inventory and working capital investments.
Plexus (Nasdaq:PLXS) - Stock Analysis
Plexus Corp. (Nasdaq:PLXS) analysis reveals it is currently 26.4% overvalued with a fair value of US$210.8, despite strong past performance and future earnings growth forecasts of 13.23% annually. The company recently reported record Q2 2026 revenues and upgraded its guidance, but has seen significant insider selling. Plexus provides electronic manufacturing services across aerospace, defense, healthcare, and industrial sectors, with its stock performance exceeding both the US Electronic industry and the broader US Market over the past year.
Todd Kelsey Sells 1,000 Shares of Plexus (NASDAQ:PLXS) Stock
Plexus CEO Todd Kelsey sold 1,000 shares of the company's stock for $270,750, reducing his stake by 1.34%. The sale leaves him with 73,888 shares worth approximately $20 million. This transaction follows Plexus reporting strong Q1 earnings, beating estimates with $2.05 EPS and achieving $1.16 billion in revenue, an 18.7% increase year-over-year.
Plexus (NASDAQ:PLXS) CEO Sells $805,350.00 in Stock
Plexus (NASDAQ:PLXS) CEO Todd Kelsey sold 3,000 shares of the company's stock for $805,350 on May 5th, reducing his stake by 3.85%. This comes after Plexus reported strong quarterly earnings, beating expectations with $2.05 EPS and $1.16 billion in revenue, and issued optimistic Q3 2026 guidance. The stock is currently trading near $265 with a market capitalization of $7.1 billion, and analysts generally rate it as a "Moderate Buy".
Plexus (NASDAQ:PLXS) CEO Sells $634,127.67 in Stock
Plexus CEO Todd Kelsey sold 2,403 shares of the company's stock for over $634,000 on May 4th, reducing his ownership by 2.99%. The transaction follows a strong Q2 2026 earnings report where Plexus beat revenue and EPS estimates and provided optimistic Q3 guidance. Despite the insider sale, analysts maintain a "Moderate Buy" rating for the stock.
Plexus Corp president & CEO Todd Kelsey divests $1.71m in shares
Plexus Corp President and CEO Todd Kelsey sold 6,403 shares of company stock between May 4 and May 6, 2026, totaling over $1.71 million. The sales occurred as the stock neared its 52-week high after a significant 111% gain. Following these transactions, Kelsey's direct ownership stands at 73,888 shares, with the divestment coinciding with the company's strong Q2 2026 financial results that surpassed expectations, despite a subsequent dip in after-hours trading.
Multiple insider sales reported at PLXS (NASDAQ: PLXS) — shares and proceeds listed
PLXS insiders have filed Form 144, reporting proposed and recently completed sales of Common Stock and Performance Stock Units. The filing includes dispositions of 3,000 shares on May 5, 2026, for $805,350.00, and 2,403 shares on May 4, 2026, for $634,139.00, among other sales. Todd P. Kelsey and Kelly M. Liv (trust/individual) are identified as the sellers.
Plexus (NASDAQ: PLXS) CEO trims stake with 6,403-share sale
Plexus Corp President & CEO Todd P. Kelsey sold 6,403 shares of Plexus common stock in open-market transactions between May 4-6, 2026. The sales were executed at prices ranging from $263.00 to $270.75 per share, totaling approximately $1.71 million. Following these transactions, Kelsey directly owns 73,888 shares of Plexus common stock.
What Is Plexus Corp.'s (NASDAQ:PLXS) Share Price Doing?
This article analyzes Plexus Corp.'s share price performance, highlighting its 30% increase over the past five years and its current trading at US$107, which is close to its intrinsic value of US$103. The analysis suggests the stock is fairly valued, with potential for future returns dependent on earnings growth.
PLXS (NASDAQ) insider sales: 3,000-share resale listed; recent dispositions shown
Plexus Corp (PLXS) reported a proposed resale of 3,000 common shares associated with Performance Stock Units dated November 13, 2024, according to a recent Form 144 SEC filing. The filing also disclosed several insider dispositions over the past three months, including sales of 2,403, 1,500, 1,500, and 5,231 shares on various dates in 2026, with specific dollar amounts for each transaction. These disclosures are standard for Form 144, indicating potential future sales and detailing recent insider activity.
Vanguard Group Inc. Decreases Position in Plexus Corp. $PLXS
Vanguard Group Inc. reduced its stake in Plexus Corp. (NASDAQ:PLXS) by 1.4% in the fourth quarter of 2025, now owning 13.58% of the company valued at approximately $534 million. Despite the institutional selling and insider activity, Plexus reported strong quarterly earnings, beating analyst expectations for both EPS and revenue and providing optimistic Q3 2026 guidance. Analyst consensus on Plexus is currently a "Moderate Buy" with an average price target of $229.17.
Todd Kelsey reports PLXS share sales via Morgan Stanley (NASDAQ: PLXS)
Todd P. Kelsey reported multiple Rule 144 share sales of Plexus Corp (PLXS) common stock through Morgan Stanley Smith Barney LLC. The transactions included sales of 5,231 shares on February 18, 2026, for $1,024,111.55; 1,500 shares on March 18, 2026, for $291,360.00; and 1,500 shares on April 15, 2026, for $336,130.05. These routine regulatory filings disclose the timing, share counts, and gross proceeds of the sales.
Plexus Corp. $PLXS Shares Bought by Universal Beteiligungs und Servicegesellschaft mbH
Universal Beteiligungs und Servicegesellschaft mbH increased its stake in Plexus Corp. by 66.4% in the fourth quarter, amidst increased buy-ins from other institutional investors. The technology company reported strong Q2 results, beating revenue and EPS estimates, and issued positive Q3 guidance, leading to an analyst upgrade and increased price target. However, the company faces near-term risks due to CFO turnover and recent insider selling.
Earnings Beat, Raised Outlook and CFO Shift Might Change The Case For Investing In Plexus (PLXS)
Plexus Corp. (PLXS) reported strong fiscal Q2 2026 results with an earnings beat, raising its Q3 guidance for revenue and EPS. The company also announced a CFO transition, with internal executive David Abuhl taking over from Patrick Jermain. These developments reinforce the company's investment narrative, emphasizing its growing pipeline of manufacturing programs while managing existing risks.
Analysts Offer Insights on Technology Companies: Zeta Global Holdings Corp (ZETA), Plexus (PLXS) and Monolithic Power (MPWR)
Three analysts have issued bullish sentiments on technology companies Zeta Global Holdings Corp (ZETA), Plexus (PLXS), and Monolithic Power (MPWR). Truist Financial reiterated a Buy rating on Zeta Global with a $30.00 price target, while Benchmark Co. maintained a Buy rating on Plexus with a $285.00 price target. Truist Financial also reiterated a Buy rating on Monolithic Power, setting a price target of $1805.00.
Plexus Corp stock hits all-time high at 262.1 USD
Plexus Corp (PLXS) stock reached an all-time high of $263, marking a 102% increase over the past year. Despite its strong performance and robust Q2 2026 financial results which surpassed earnings and revenue forecasts, InvestingPro analysis suggests the stock might be overvalued relative to its Fair Value. The stock's RSI indicates it is in overbought territory, though it trades near its 52-week high.
Plexus Corp. (NASDAQ:PLXS) Q2 2026 Earnings Call Transcript
Plexus Corp. (NASDAQ:PLXS) reported strong Q2 2026 earnings, exceeding guidance with $1.164 billion in revenue and $2.05 non-GAAP EPS. The company secured a record $355 million in new manufacturing program wins and increased its fiscal 2026 revenue growth forecast to mid-teens or greater, driven by demand in aerospace and defense and industrial sectors. Plexus also announced the retirement of CFO Pat Jermain and the appointment of David Abuhl as his successor, while maintaining a focus on operational efficiency and sustainable growth.
Vanguard holds 1.4M Plexus shares (PLXS) — 5.22% stake
Vanguard Capital Management reported a 5.22% beneficial ownership stake in Plexus Corp (PLXS), holding 1,400,048 shares as of March 31, 2026. The Schedule 13G filing indicates Vanguard has sole dispositive power over all these shares and sole voting power for 201,847 shares. This disclosure reflects a passive investment, not implying active control over Plexus.
